Cardinal Capital Management grew its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 4.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 73,561 shares of the medical research company's stock after buying an additional 3,236 shares during the quarter. Agilent Technologies makes up 1.3% of Cardinal Capital Management's portfolio, making the stock its 23rd largest position. Cardinal Capital Management's holdings in Agilent Technologies were worth $8,681,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in A. Brighton Jones LLC increased its position in Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares in the last quarter. Vise Technologies Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $320,000. GTS Securities LLC increased its holdings in shares of Agilent Technologies by 104.9% in the fourth quarter. GTS Securities LLC now owns 2,380 shares of the medical research company's stock valued at $320,000 after purchasing an additional 51,066 shares in the last quarter. Sunbelt Securities Inc. increased its holdings in shares of Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Finally, Toronto Dominion Bank increased its stake in shares of Agilent Technologies by 5.8% in the 4th quarter. Toronto Dominion Bank now owns 153,898 shares of the medical research company's stock valued at $20,674,000 after buying an additional 8,420 shares during the period.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. lowered their target price on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research note on Thursday, May 29th. Leerink Partners lifted their price objective on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday, May 30th. Wells Fargo & Company lifted their price objective on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research report on Monday, September 15th. Wall Street Zen cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Finally, UBS Group lowered their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $140.08.
Check Out Our Latest Report on A
Insider Activity
In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Agilent Technologies Price Performance
Shares of A stock opened at $126.36 on Tuesday. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a market capitalization of $35.82 billion, a price-to-earnings ratio of 29.66, a price-to-earnings-growth ratio of 3.93 and a beta of 1.24. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The firm has a fifty day moving average of $120.37 and a 200-day moving average of $115.81.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the business earned $1.32 EPS. The firm's revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. Agilent Technologies's payout ratio is currently 23.24%.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
